Mario Guralnik

A placebo-controlled trial of the immune modulator, lentinan, in HIV-positive patients: a phase I/II trial.

Murray Gordon, Bernard Bihari, Eric Goosby et al. · PubMed · 1998 · 57 citations

Medicine, Immunology, Pharmacology +14

A phase I study of curdlan sulfate--an HIV inhibitor. Tolerance, pharmacokinetics and effects on coagulation and on CD4 lymphocytes.

Mónica Gordón, Mario Guralnik, Yoshinori Kaneko et al. · PubMed · 1994 · 39 citations

Medicine, Pharmacokinetics, Pharmacology +12

A phase II controlled study of a combination of the immune modulator, lentinan, with didanosine (ddI) in HIV patients with CD4 cells of 200-500/mm3.

M Gordon, Mario Guralnik, Y. Kaneko et al. · PubMed · 1995 · 28 citations

Medicine, Infectious Diseases, Pharmacology +17

Curdlan sulfate (CRDS) in a 21-day intravenous tolerance study in human immunodeficiency virus (HIV) and cytomegalovirus (CMV) infected patients: indication of anti-CMV activity with low toxicity.

Mónica Gordón, Steven G. Deeks, C De Marzo et al. · PubMed · 1997 · 27 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Preclinical In Vitro Activity of QR-435 Against Influenza A Virus as a Virucide and in Paper Masks for Prevention of Viral Transmission

John Oxford, Mario Guralnik, Richard A Rosenbloom et al. · American Journal of Therapeutics · 2007 · 21 citations

Pharmacy, Infectious Diseases, Medicinal Chemistry +15